Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A mouse model of renal cell carcinoma.

Literature DB >> 28697179

A mouse model of renal cell carcinoma.

Laura S Schmidt^1,2,2, W Marston Linehan².

Abstract

Entities: Disease Species

Mesh：

Year: 2017 PMID： 28697179 DOI： 10.1038/nm.4366

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

12 in total

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396

2. Integrated molecular analysis of clear-cell renal cell carcinoma.

Authors: Yusuke Sato; Tetsuichi Yoshizato; Yuichi Shiraishi; Shigekatsu Maekawa; Yusuke Okuno; Takumi Kamura; Teppei Shimamura; Aiko Sato-Otsubo; Genta Nagae; Hiromichi Suzuki; Yasunobu Nagata; Kenichi Yoshida; Ayana Kon; Yutaka Suzuki; Kenichi Chiba; Hiroko Tanaka; Atsushi Niida; Akihiro Fujimoto; Tatsuhiko Tsunoda; Teppei Morikawa; Daichi Maeda; Haruki Kume; Sumio Sugano; Masashi Fukayama; Hiroyuki Aburatani; Masashi Sanada; Satoru Miyano; Yukio Homma; Seishi Ogawa
Journal: Nat Genet Date: 2013-06-24 Impact factor: 38.330

Review 3. A clearer view of the molecular complexity of clear cell renal cell carcinoma.

Authors: Ian J Frew; Holger Moch
Journal: Annu Rev Pathol Date: 2014-10-27 Impact factor: 23.472

4. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.

Authors: Shan-Shan Wang; Yi-Feng Gu; Nicholas Wolff; Karoliina Stefanius; Alana Christie; Anwesha Dey; Robert E Hammer; Xian-Jin Xie; Dinesh Rakheja; Ivan Pedrosa; Thomas Carroll; Renée M McKay; Payal Kapur; James Brugarolas
Journal: Proc Natl Acad Sci U S A Date: 2014-10-30 Impact factor: 11.205

5. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

Authors: Stefano J Mandriota; Kevin J Turner; David R Davies; Paul G Murray; Neil V Morgan; Heidi M Sowter; Charles C Wykoff; Eamonn R Maher; Adrian L Harris; Peter J Ratcliffe; Patrick H Maxwell
Journal: Cancer Cell Date: 2002-06 Impact factor: 31.743

6. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

Authors: Michael L Nickerson; Erich Jaeger; Yangu Shi; Jeffrey A Durocher; Sunil Mahurkar; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Anush Mukeria; Ivana Holcatova; Laura S Schmidt; Jorge R Toro; Sara Karami; Rayjean Hung; Gary F Gerard; W Marston Linehan; Maria Merino; Berton Zbar; Paolo Boffetta; Paul Brennan; Nathaniel Rothman; Wong-Ho Chow; Frederic M Waldman; Lee E Moore
Journal: Clin Cancer Res Date: 2008-08-01 Impact factor: 12.531

A mouse model of renal cell carcinoma.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

2. Integrated molecular analysis of clear-cell renal cell carcinoma.

Review 3. A clearer view of the molecular complexity of clear cell renal cell carcinoma.

4. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.

5. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.

6. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

7. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.

8. Combined Deletion of Vhl and Kif3a Accelerates Renal Cyst Formation.

9. Comprehensive molecular characterization of clear cell renal cell carcinoma.

10. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics.

1. Editorial: in vitro and in vivo non-clinical models of kidney cancers.

2. βArrestin2 Mediates Renal Cell Carcinoma Tumor Growth.